Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets
NCT ID: NCT01089582
Last Updated: 2011-04-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
628 participants
OBSERVATIONAL
2007-11-30
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes
NCT00630851
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
NCT02162264
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
NCT00096473
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
NCT00165763
A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI
NCT00483028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AD patients
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pfizer, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Alexandroupolis Dimokritio
Alexandroupoli, Thrace, Greece
General Hospital of Arta
Arta, , Greece
NIMITS (Geriatric Department)
Athens, , Greece
NIMITS Geriatric Department
Athens, , Greece
General Hospital of Athens Laikon Dementia Department
Athens, , Greece
Naval Hospital, Dementia Department
Athens, , Greece
General State Hospital "G. Genimatas", Neurology Department
Athens, , Greece
ATTIKON University General Hospital (Dementia Department)
Athens, , Greece
Psychiatric Hospital of Attica Dromokaiteio, Psychiatric Department
Athens, , Greece
1st IKA Hospital Neurology Clinic
Athens, , Greece
Sismanogleio Psychiatric Clinic
Athens, , Greece
HYGEIA Diagnostic & Therapeutic Center of Athens Internal Medicine Department
Athens, , Greece
251 General air force hospital
Athens, , Greece
Psychiatric Hospital, Psychogeriatric Clinic
Chaïdári, , Greece
Venizeleio General Hospital
Crete, , Greece
Hospital of Chania
Crete, , Greece
Hospital of Giannitsa
Giannitsá, , Greece
University General Hospital
Ioannina, , Greece
General Hospital of Ioannina
Ioannina, , Greece
Center of Psychiatric Health of Katerini
Katerini, , Greece
General Hospital Neurological Clinic
Kavala, , Greece
Ag. Andreas
Pátrai, , Greece
A.H.E.P.A University General Hospital of Thessaloniki
Thessaloniki, , Greece
B´ IKA Panagia Hospital, Dementia Departments
Thessaloniki, , Greece
Papageorgiou hospital
Thessaloniki, , Greece
Psychiatric hospital, 1st Psychogeriatric Department
Thessaloniki, , Greece
Psychiatric Hospital of Thessaloniki, Psychiatric Department
Thessaloniki, , Greece
G. Papanikolaou Hospital 3rd Neurology Clinic
Thessaloniki, , Greece
Centre of Psychiatric Health
Tripoli, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A2501054
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.